Kore Private Wealth’s Quest Diagnostics DGX Stock Holding History

Kore Private Wealth’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-442	Closed	-$50K	–	470
2020 Q2	$50K	Sell	442 -13	-3%	-$1.38K	0.01%	456
2020 Q1	$37K	Sell	455 -25	-5%	-$2.59K	0.01%	474
2019 Q4	$51K	Buy	+480	New	+$50.1K	0.01%	477
2019 Q2	–	Sell	-470	Closed	-$42K	–	371
2019 Q1	$42K	Hold	470	–	–	0.01%	410
2018 Q4	$39K	Buy	+470	New	+$44.1K	0.01%	411

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Kore Private Wealth's DGX Position: Q3 2020 in Review

Kore Private Wealth sold out of Quest Diagnostics (DGX) in Q3 2020, closing a stake of 442 shares — an estimated $50K sold.

Kore Private Wealth first reported a position in DGX in Q4 2018 and held it in 5 quarters. The position peaked at $51K in Q4 2019. 757 funds tracked by Wall St. Rank hold DGX as of Q3 2020.

Kore Private Wealth reported no remaining Quest Diagnostics position as of Q3 2020 after selling out during the quarter.
Kore Private Wealth sold 442 Quest Diagnostics shares in Q3 2020, an estimated $50K.
Kore Private Wealth first reported a position in Quest Diagnostics in Q4 2018 and held it in 5 quarters.
Kore Private Wealth's Quest Diagnostics position peaked at $51K in Q4 2019.
757 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2020.

Based on Kore Private Wealth's 13F filing for Q3 2020, filed 13 Nov 2020.